Eversana Intouch Executive and Leadership Team

Amir BenAly, the Chief Executive Officer at Eversana Intouch, directs the overarching strategic vision for the commercial services platform. By aligning agency capabilities with field deployment and pharmacy distribution expertise, the Chief Executive Officer ensures seamless product delivery for pharmaceutical clients. Amir BenAly drives the integration of advocacy group insights into every brand strategy, fostering deeper connections between medical providers and patient needs. This leadership role involves constant evaluation of market trends to maintain a competitive edge in the healthcare marketing sector. Through rigorous oversight of organizational performance, the Chief Executive Officer optimizes internal processes to support long-term growth. By championing a culture of innovation, the Chief Executive Officer empowers teams to solve complex commercial challenges. Ultimately, the Chief Executive Officer secures the firm's position as a leader in the life sciences industry by prioritizing measurable patient outcomes and sustainable commercial success.

Angela Tenuta, the Global Group President at Eversana Intouch, oversees international expansion and the scaling of commercial services across diverse markets. By directing global initiatives, the Global Group President ensures that the firm's integrated platform delivers consistent value to multinational pharmaceutical clients. Angela Tenuta manages the alignment of regional operations with the company's core mission of improving patient outcomes through innovative marketing. This leadership role involves fostering partnerships with global stakeholders to optimize pharmacy distribution and field deployment strategies. By identifying growth opportunities in emerging healthcare sectors, the Global Group President expands the firm's footprint and influence. The Global Group President also coordinates with other C-suite leaders to ensure that global strategies support the overarching commercial objectives. Through strategic oversight of international teams, the Global Group President drives operational excellence and market penetration. Ultimately, the Global Group President secures the firm's reputation as a premier global partner in the life sciences industry.

Ann Cave, the President, Full Service Agencies at Eversana Intouch, directs the creative and strategic output of the agency portfolio. By overseeing the full spectrum of marketing services, the President, Full Service Agencies ensures that every campaign reflects the firm's deep understanding of patient services and product delivery. Ann Cave manages the integration of creative teams with technical experts to produce high-impact brand solutions. This leadership role involves driving the development of comprehensive marketing strategies that span from pre-launch planning to post-market value demonstration. By optimizing agency workflows, the President, Full Service Agencies enhances the quality and speed of service delivery for clients. The President, Full Service Agencies also collaborates with other executives to ensure that agency output remains aligned with the broader commercial services platform. Through a focus on innovation and client satisfaction, the President, Full Service Agencies supports the firm's growth. Ultimately, the President, Full Service Agencies delivers superior brand success through creative excellence.

Boris Kushkuley, the Group President at Eversana Intouch, leads the development and execution of specialized commercial solutions for the firm's diverse client base. By focusing on the intersection of pharmacy distribution and patient services, the Group President architects programs that maximize product accessibility and adherence. Boris Kushkuley manages the strategic direction of specific business units to ensure they meet the evolving needs of the healthcare market. This leadership role involves analyzing market data to refine service offerings and improve the efficiency of commercial deployments. By collaborating with internal experts in field deployment, the Group President ensures that every solution is fully integrated into the company's broader platform. The Group President also mentors team leaders to foster a culture of accountability and high performance. Through the implementation of data-driven strategies, the Group President drives revenue growth and operational success. Ultimately, the Group President secures the firm's competitive advantage by delivering tailored, high-value commercial solutions.

Cortnee Scale, the Chief of Staff at Eversana Intouch, manages the operational execution of executive priorities across the organization. By coordinating cross-functional initiatives, the Chief of Staff ensures that agency resources align with the broader commercial services platform goals. Cortnee Scale facilitates communication between leadership tiers, streamlining decision-making processes to enhance organizational agility. This role involves monitoring key performance indicators related to pre-launch planning and patient service delivery. By identifying operational bottlenecks, the Chief of Staff implements solutions that improve efficiency across all departments. The Chief of Staff also oversees the implementation of strategic projects that connect pharmacy distribution networks with marketing efforts. Through meticulous planning and resource allocation, the Chief of Staff supports the firm's mission to provide comprehensive value to patients. Ultimately, the Chief of Staff maintains the operational rhythm necessary for the company to thrive in a complex, highly regulated healthcare environment.

Joseph Wellington, the Chief Medical Officer at Eversana Intouch, provides clinical expertise to guide the development of evidence-based marketing strategies. By analyzing how doctors prescribe and how products impact patient health, the Chief Medical Officer ensures that all commercial messaging remains scientifically accurate and clinically relevant. Joseph Wellington collaborates with advocacy groups to integrate patient perspectives into the product lifecycle, from initial launch to real-world value assessment. This leadership role involves interpreting complex medical data to inform the agency's approach to pharmacy distribution and patient support services. By bridging the gap between clinical research and commercial execution, the Chief Medical Officer enhances the credibility of the firm's service offerings. The Chief Medical Officer also advises the executive team on emerging medical trends that could influence future market opportunities. Ultimately, the Chief Medical Officer drives the scientific integrity of the organization, ensuring that every strategy prioritizes patient safety and therapeutic efficacy.